|
|
2,5-Methano-5H-pyrimido[1,2-c][1,3,5]oxadiazepin-9(1H)-one, 1-amino-3-[(benzoyloxy)methyl]-2,3-dihydro-11-hydroxy-, [2R-(2α,3β,5α,11S*)]-
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
[1,4]Oxathiino[3,2-c:5,6-c′]dipyridine-1,9(2H,8H)-dione, 2,8-bis(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-, 10-oxide
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
Adenosine, 2,2′′-(1,3-butadiyne-1,4-diyl)bis-, 2′,2′′′,3′,3′′′,5′,5′′′-hexaacetate
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|
|
|
|
|
|
Pricing
|